What is dTMS?
Deep transcranial magnetic stimulation, also known as Deep TMS (dTMS), is an in-office, FDA approved, non-drug, non-invasive treatment for people suffering from major depressive disorder (MDD) and Obsessive Compulsive Disorder (OCD). dTMS therapy is CE (Europe) to assist with Postpartum Depression, Post-Traumatic Stress Disorder, (PTSD), other anxiety disorders, tinnitus, smoking cessation, and other neurological disorders.
Unlike regular TMS, dTMS, utilizes H coils that can penetrate the 4 cm beneath the surface of the skull. Allowing for the wider efficacy when stimulating the neuronal circuits in the prefrontal cortex, which is under functioning in people with MDD.
This low-stress procedure administers electromagnetic pulses without any sedation or anesthesia. Completed on an outpatient basis, dTMS is completed in 18-20 minutes under the supervision of the TMS coordinator. After relaxing 18-20 minutes, people undergoing the treatment are free to leave without supervision and continue living their life.
How dTMS Works
dTMS requires 5 daily sessions that last only 20 minutes, over just 4-6 weeks depending the response to treatment. The treatment integrates well into the patient’s routine, and the patient can drive home independently after each session to resume his/her daily activities.
Benefits of dTMS
dTMS has been illuminating the path to freedom from treatment resistant depression for many years now. Just becoming FDA approved for OCD treatment, dTMS is proving its versatility in assisting people get better and stay better.
BrainsWay Treatment vs. Antidepressants
|Side Effects||The most common side effect is temporary, mild pain or discomfort at or around the site of TMS application, which occurs during treatment. This typically occurs only during the first week of treatment. There is a rare risk of seizure.*||The most common side effects include the following: Nausea, insomnia, anxiety, weight gain and sexual dysfunction, as well as diarrhea, dry mouth, and sweating.|
|Overall treatment term||Limited to the depressive episode, with an option for maintenance, if required.||Generally, antidepressants are prescribed for an indefinite or permanent period.|
|Clinical results achieved in||4-6 weeks||4-6 weeks|
BrainsWay Treatment vs. ECT
|Side Effects||The most common side effect is temporary, mild pain or discomfort at or around the site of TMS application, which occurs during treatment. This typically occurs only during the first week of treatment. There is a rare risk of seizure.*||Common side effects: Cognitive and memory dysfunction, alterations in blood pressure, pain and discomfort. Rare side effects: Adverse reactions to anesthesia, cardiovascular complications, death.|
|Session length||20 minutes||Several hours, including anesthesia and recovery|
|Overall treatment term||20-30 sessions in the acute phase||Typically 6-12 sessions, in the acute phase|
|Procedure||Non-invasive electromagnetic stimulation of brain regions||Electrically induced seizures|
|Hospitalization||None||Often requires partial hospitalization (day hospitalization)|
|Recovery time after each session||Minutes – patient can drive home independently||Hours to days|
Rare risk of seizures*
*<0.1% of the population, which is significantly lower than antidepressants or ECT
What Can dTMS Treat?
Same Technology Found At: